Moderna (MRNA) call put ratio 1.6 calls to 1 put into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Moderna (MRNA) PT Lowered to $25 at Wolfe Research
February 14, 2025 2:07 PM ESTWolfe Research analyst Alexandria Hammond lowered the price target on Moderna (NASDAQ: MRNA) to $25.00 (from $35.00) while maintaining a Underperform rating.
The analyst comments "We revised our FY2025 rev/EPS #'s downward. Cost management, Roivant litigation (potential trial in Sept), CMV... More
